WO2003103685A1 - A method of treating human skin and a skin care composition for use in such a method - Google Patents
A method of treating human skin and a skin care composition for use in such a method Download PDFInfo
- Publication number
- WO2003103685A1 WO2003103685A1 PCT/NL2003/000420 NL0300420W WO03103685A1 WO 2003103685 A1 WO2003103685 A1 WO 2003103685A1 NL 0300420 W NL0300420 W NL 0300420W WO 03103685 A1 WO03103685 A1 WO 03103685A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- composition
- estrogenic component
- estrogenic
- cosmetically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003274941A AU2003274941A1 (en) | 2002-06-11 | 2003-06-11 | A method of treating human skin and a skin care composition for use in such a method |
US10/517,509 US7943604B2 (en) | 2002-06-11 | 2003-06-11 | Method of treating human skin and a skin care composition for use in such a method |
CA2489270A CA2489270C (en) | 2002-06-11 | 2003-06-11 | A method of treating human skin and a skin care composition for use in such a method |
ES03741632T ES2399423T3 (en) | 2002-06-11 | 2003-06-11 | Method for treating human skin and a skin care composition for use in such method |
EP03741632A EP1511498B1 (en) | 2002-06-11 | 2003-06-11 | A method of treating human skin and a skin care composition for use in such a method |
US13/017,858 US9040509B2 (en) | 2002-06-11 | 2011-01-31 | Method of treating human skin and a skin care composition for use in such a method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02077273 | 2002-06-11 | ||
EP02077273.7 | 2002-06-11 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US51750903A A-371-Of-International | 2002-06-11 | 2003-06-11 | |
US13/017,858 Division US9040509B2 (en) | 2002-06-11 | 2011-01-31 | Method of treating human skin and a skin care composition for use in such a method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003103685A1 true WO2003103685A1 (en) | 2003-12-18 |
Family
ID=29724475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2003/000420 WO2003103685A1 (en) | 2002-06-11 | 2003-06-11 | A method of treating human skin and a skin care composition for use in such a method |
Country Status (7)
Country | Link |
---|---|
US (2) | US7943604B2 (en) |
EP (1) | EP1511498B1 (en) |
CN (1) | CN100352445C (en) |
AU (1) | AU2003274941A1 (en) |
CA (1) | CA2489270C (en) |
ES (1) | ES2399423T3 (en) |
WO (1) | WO2003103685A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008085038A2 (en) * | 2007-01-08 | 2008-07-17 | Pantarhei Bioscience B.V. | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
EP2189788A1 (en) * | 2007-09-12 | 2010-05-26 | Kao Corporation | Method for quantification of steroid hormone |
WO2021044302A1 (en) | 2019-09-03 | 2021-03-11 | Richter Gedeon Nyrt. | Industrial process for the preparation of high purity estetrol |
WO2023094690A1 (en) | 2021-11-29 | 2023-06-01 | Estetra Srl | Compositions for promoting hair growth |
WO2023094689A1 (en) | 2021-11-29 | 2023-06-01 | Estetra Srl | Compositions for preventing or treating skin aging |
WO2024074700A1 (en) * | 2022-10-07 | 2024-04-11 | Neuralis Sa | Topical compositions comprising an estetrol component and use of said compositions for wound healing |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8924922B2 (en) * | 2010-06-14 | 2014-12-30 | Microsoft Corporation | Pre-compiling hosted managed code |
LT2714712T (en) | 2011-06-01 | 2016-11-25 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
US11053274B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
HUE055562T2 (en) | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
WO2013034780A2 (en) | 2012-12-20 | 2013-03-14 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol and related compounds |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2015040051A1 (en) | 2013-09-18 | 2015-03-26 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol |
EP3145489A1 (en) | 2014-05-22 | 2017-03-29 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
PL3310346T3 (en) | 2015-06-18 | 2021-10-25 | Estetra Sprl | Orodispersible tablet containing estetrol |
TN2017000499A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
US11147771B2 (en) | 2015-06-18 | 2021-10-19 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
ES2877186T3 (en) | 2015-06-18 | 2021-11-16 | Estetra Sprl | Orodispersible tablet containing estetrol |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (en) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | pharmaceutical composition of steroid hormone |
KR20220144885A (en) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | Method for the management of dysmenorrhea and menstrual pain |
TWI801561B (en) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | Compounds and their uses for alleviating menopause-associated symptoms |
JOP20200260A1 (en) | 2018-04-19 | 2019-10-19 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000062753A1 (en) * | 1999-04-16 | 2000-10-26 | Jenapharm Gmbh & Co. Kg | Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones |
WO2003018026A1 (en) * | 2001-08-31 | 2003-03-06 | Pantarhei Bioscience B.V. | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3440320A (en) | 1964-06-18 | 1969-04-22 | Mortimer D Sackler | Chelated suppository and method of using same |
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
DE2336433A1 (en) | 1973-07-13 | 1975-04-03 | Schering Ag | 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity |
DE2426779A1 (en) | 1974-05-31 | 1975-12-18 | Schering Ag | 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity |
DE2336434A1 (en) | 1973-07-13 | 1975-04-17 | Schering Ag | 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity |
US4722941A (en) | 1978-06-07 | 1988-02-02 | Kali-Chemie Pharma Gmbh | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof |
US4460372A (en) | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
US4573996A (en) | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4624665A (en) | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
US4937238A (en) | 1986-03-04 | 1990-06-26 | The Board Of Regents Of The University Of Nebraska | Prevention of mammary carcinoma |
US4762717A (en) | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
US5223261A (en) | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US5043331A (en) | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
US5130137A (en) | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
JPH04235171A (en) | 1990-07-26 | 1992-08-24 | Sumitomo Chem Co Ltd | Sulfohydroxamic acid derivative, production thereof and herbicide containing the same derivative as active ingredient |
US5063507A (en) | 1990-09-14 | 1991-11-05 | Plains Cotton Cooperative Association | Goods database employing electronic title or documentary-type title |
US5340585A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
US5211952A (en) | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5340586A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Methods and formulations for use in treating oophorectomized women |
US5468736A (en) | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
US5895783A (en) | 1993-07-16 | 1999-04-20 | Schering Aktiengesellschaft | Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
NL9301562A (en) | 1993-09-09 | 1995-04-03 | Saturnus Ag | Substitution therapy preparation. |
DE4344405C2 (en) | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Anti-ovulation agent and method for hormonal contraception |
WO1996003929A1 (en) | 1994-08-04 | 1996-02-15 | Biex, Inc. | Method for prediction of premature delivery using estetrol (e4) as an indicator |
DE4429374C1 (en) | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component |
DK0994718T3 (en) | 1997-06-20 | 2005-12-19 | Akzo Nobel Nv | Gonadotropin releasing hormone antagonist |
DE19739916C2 (en) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands |
US6214815B1 (en) | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
DE19917930A1 (en) | 1999-04-15 | 2000-10-19 | Schering Ag | Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity |
AU5137900A (en) | 1999-05-28 | 2000-12-18 | University Of Cincinnati, The | Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
WO2001030356A1 (en) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Hormonal composition based on a progestational agent and an oestrogen and use thereof |
DE60129550T2 (en) | 2000-05-12 | 2008-04-10 | The Government Of The United States Of America, As Represented By The Department | USE OF LOW DOSE ESTROGENS IN COMBINATION WITH IMMUNOTHERAPEIC COMPOUNDS FOR THE TREATMENT OF IMMUNE DISEASES |
CA2462081A1 (en) * | 2000-10-11 | 2002-04-18 | Laura Kragie | Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
US6936599B2 (en) | 2001-04-25 | 2005-08-30 | The Regents Of The University Of California | Estriol therapy for multiple sclerosis and other autoimmune diseases |
EP1260225A1 (en) | 2001-05-18 | 2002-11-27 | Pantarhei Bioscience B.V. | A pharmaceutical composition for use in hormone replacement therapy |
-
2003
- 2003-06-11 WO PCT/NL2003/000420 patent/WO2003103685A1/en not_active Application Discontinuation
- 2003-06-11 CA CA2489270A patent/CA2489270C/en not_active Expired - Lifetime
- 2003-06-11 US US10/517,509 patent/US7943604B2/en active Active
- 2003-06-11 ES ES03741632T patent/ES2399423T3/en not_active Expired - Lifetime
- 2003-06-11 CN CNB038188449A patent/CN100352445C/en not_active Expired - Lifetime
- 2003-06-11 EP EP03741632A patent/EP1511498B1/en not_active Expired - Lifetime
- 2003-06-11 AU AU2003274941A patent/AU2003274941A1/en not_active Abandoned
-
2011
- 2011-01-31 US US13/017,858 patent/US9040509B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000062753A1 (en) * | 1999-04-16 | 2000-10-26 | Jenapharm Gmbh & Co. Kg | Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones |
WO2003018026A1 (en) * | 2001-08-31 | 2003-03-06 | Pantarhei Bioscience B.V. | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
Non-Patent Citations (4)
Title |
---|
A. O. MUECK, H. SEEGER, C. LIPPERT & D. WALLWIENER: "Angiogenetic and anti-angiogenetic effects of estradiol and its metabolites.", J. CLIN. BASIC CARDIOL., vol. 4, no. 2, 2001, pages 153 - 155, XP008004903 * |
J.B. SCHMIDT, M. BINDER, G. DEMSCHIK, C. BIEGLMAYER & A. REINER: "Treatment of skin aging with topical estrogens", INT. J. DERMATOL., vol. 35, no. 9, 1996, pages 669 - 674, XP002220744 * |
M. G. SHAH & H. I. MAIBACH: "Estrogen and skin. An overview", AM. J. CLIN. DERMATOL., vol. 2, no. 3, 2001, pages 143 - 150, XP002220743 * |
R. SITRUK-WARE & J.-L. THOMAS: "Local hormonal treatment for urogenital atrophy after menopause", SCHWEIZ. RUNDSCH. MED. PRAXIS, vol. 86, no. 33, 1997, pages 1245 - 1248, XP001119587 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008085038A2 (en) * | 2007-01-08 | 2008-07-17 | Pantarhei Bioscience B.V. | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
WO2008085038A3 (en) * | 2007-01-08 | 2008-09-12 | Pantarhei Bioscience Bv | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
CN101583363B (en) * | 2007-01-08 | 2013-08-21 | 潘塔希生物科学股份有限公司 | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
EP2189788A1 (en) * | 2007-09-12 | 2010-05-26 | Kao Corporation | Method for quantification of steroid hormone |
EP2189788A4 (en) * | 2007-09-12 | 2010-10-13 | Kao Corp | Method for quantification of steroid hormone |
US8017404B2 (en) | 2007-09-12 | 2011-09-13 | Kao Corporation | Steroid hormone assay method |
WO2021044302A1 (en) | 2019-09-03 | 2021-03-11 | Richter Gedeon Nyrt. | Industrial process for the preparation of high purity estetrol |
US11633406B2 (en) | 2019-09-03 | 2023-04-25 | Richter Gedeon Nyrt. | Industrial process for the preparation of high purity estetrol |
WO2023094690A1 (en) | 2021-11-29 | 2023-06-01 | Estetra Srl | Compositions for promoting hair growth |
WO2023094689A1 (en) | 2021-11-29 | 2023-06-01 | Estetra Srl | Compositions for preventing or treating skin aging |
WO2024074700A1 (en) * | 2022-10-07 | 2024-04-11 | Neuralis Sa | Topical compositions comprising an estetrol component and use of said compositions for wound healing |
Also Published As
Publication number | Publication date |
---|---|
CA2489270C (en) | 2012-08-07 |
US20050215538A1 (en) | 2005-09-29 |
US20110160173A1 (en) | 2011-06-30 |
CN100352445C (en) | 2007-12-05 |
ES2399423T3 (en) | 2013-04-01 |
US7943604B2 (en) | 2011-05-17 |
EP1511498B1 (en) | 2012-11-21 |
CN1674915A (en) | 2005-09-28 |
CA2489270A1 (en) | 2003-12-18 |
US9040509B2 (en) | 2015-05-26 |
EP1511498A1 (en) | 2005-03-09 |
AU2003274941A1 (en) | 2003-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9040509B2 (en) | Method of treating human skin and a skin care composition for use in such a method | |
EP0189738B1 (en) | Topical compositions for preventing or treating dry skin | |
Creidi et al. | Effect of a conjugated oestrogen (Premarin®) cream on ageing facial skin. A comparative study with a placebo cream | |
DE60216630T2 (en) | USE OF ESTROGEN IN COMBINATION WITH PROGESTOGEN FOR HORMONE SUBSTITUTIONAL THERAPY | |
US8076314B2 (en) | Topical compositions for anti-aging and methods of using same | |
DE60209907T2 (en) | USE OF ORGANIC COMPOUNDS TO INCREASE LIBIDO IN WOMEN | |
Diamond et al. | Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women | |
JP4841778B2 (en) | Cosmetic composition containing resveratrol and retinoid | |
EP1003470B1 (en) | Skin care composition | |
NICHOLS et al. | 17β-Estradiol for postmenopausal estrogen replacement therapy | |
DE60223795T2 (en) | Tetrahydroxylated estrogen-containing drug delivery system for use in hormonal contraception | |
WO2006125642A1 (en) | Methods and apparatus for transdermal or transmucosal application of testosterone | |
CA2585666A1 (en) | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | |
Murray | Natural progesterone: what role in women’s health care | |
Marks et al. | Skin changes at the time of the climacteric | |
EP0630248B1 (en) | Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis | |
Deghenghi | Chemistry and biochemistry of natural estrogens | |
NZ210943A (en) | Dehydroepiandrosterone compositons for skin treatment | |
US20030050293A1 (en) | Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2489270 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003741632 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038188449 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003741632 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10517509 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |